National Medical Care Company SJSC

The company maintains a strong liquidity position with a current ratio of 4.3, indicating a robust ability to meet short-term obligations. However, its net cash position is negative after subtracting total debt, signaling potential liquidity risk. The debt-to-equity ratio of 0.28 suggests a conservative capital structure, with equity financing playing a dominant role in the company's operations.

Profitability metrics show a return on equity (ROE) of 17.22% and a return on assets (ROA) of 11.49%, both exceeding the typical thresholds for the healthcare industry. These figures indicate efficient use of equity and assets to generate profits. The operating margin, calculated as operating income of 354.5 million SAR on revenue of 1.6 billion SAR, reflects a healthy margin of 22.16%, which is favorable compared to industry benchmarks.

Geographically and segment-wise, the company's revenue is concentrated within Saudi Arabia, as disclosed in its financial statements. No material revenue diversification across regions or business segments is evident from the provided data. The company's exposure to a single market may pose concentration risk, particularly in the event of regulatory or economic shifts in the domestic healthcare sector.

The company's growth trajectory is supported by a positive free cash flow of 208.7 million SAR and a capital expenditure of -131.0 million SAR, indicating reinvestment in operations. Analysts project a mean price target of 177.83 SAR, with a median of 178.50 SAR, suggesting moderate optimism about the company's future performance. The mean recommendation of 2.20 (on a 1-5 scale) further supports a cautious buy stance.

Risk factors include a medium liquidity risk due to the negative net cash position after debt, and a low dilution risk as shares outstanding remain unchanged between basic and diluted counts. No recent dilutive events are reported, and the company has not issued additional shares in the period under review. The absence of dilution pressure is a positive signal for existing shareholders.

Recent filings and transcripts do not indicate any material events or strategic shifts. The company's financial performance remains stable, with no significant changes in its operational or capital structure reported in the latest disclosures.